Related content

The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis

By Nordstrom Beth L.   Knopf Kevin B.   Teltsch Dana Y.   Engle Robert   Beygi Hooman   Sterchele James A.  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1266-1273

Informa Healthcare

Access to resources Recommend Favorite

Immunochemotherapy for primary central nervous system lymphoma with rituximab, methotrexate, cytarabine and dexamethasone: Retrospective analysis of 18 cases

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 949-953

Science Publishers

Access to resources Recommend Favorite

Low dose methotrexate and vinblastine, given weekly to patients with desmoid tumours, is associated with major toxicity

By van der Hul René L.   Seynaeve Caroline   van Geel Bert N.   Verweij Jaap  

Sarcoma, Vol. 7, Iss. 3-4, 2003-01 ,pp. : 153-157

Informa Healthcare

Access to resources Recommend Favorite

Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis

By Rask Charlotte   Albertioni Freidoun   Bentzen Soeren M.   Schroeder Henrik   Peterson Curt  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 277-284

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients

By Kim Hye   Park Hyung   Kwon Woo   Lee Ji   Tanigawara Yusuke   Lim Sun   Kim Hyo   Shin Sang   Ahn Jung   Rha Sun  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 825-835

Springer Publishing Company

Access to resources Recommend Favorite